OBJECTIVE: To determine the rate of compliance with current American Colleg
e of Obstetricians and Gynecologists (ACOG) recommendations for management
of parturients undergoing cesarean delivery for persistent nonreassuring fe
tal heart rare (FHR) tracings.
STUDY DESIGN: We per formed a retrospective chart review (July 1995-June 19
98) of all parturients who underwent cesarean delivery for nonreassuring FH
X tracings. Outcome measures included maneuvers for fetal assessment (scalp
stimulation or scalp blood pH) and therapeutic interventions (tocolytic ag
ents for reducing uterine activity or amnioinfusion). Patients with multipl
e gestations and cesarean delivery for other indications were excluded. Stu
dent's t test, chi (2) and Fisher's exact tests were used; odds ratio and 9
5% confidence interval were calculated. P < .05 was considered significant.
RESULTS: Cesarean delivery for persistent nonreassuring FHR patterns includ
ed 134 (3.6%) of the 3,671 deliveries during three years. Thirty patients p
roduced intrapartum FHR tracings containing persistent variable deceleratio
ns; 12 (40%) of these patients received amnioinfusion. In only 37% (50/134)
of cases was there a documented attempt at scalp or acoustic stimulation p
rior to delivery. Scalp pH was obtained in 15% (15/98) of patients whose ce
rvix was at least 3 cm dilated. Tocolytic agents were used for intrauterine
resuscitation in 25% (34/134) of casts; their use varied significantly (P
= .006) with the type of FHR abnormality,
CONCLUSION: At our tertiary center, ACOG rerommendations for management of
nonreassuring intrapartum FHR tracings were used in a limited number of cas
es.